Hungary vs Oman: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Hungary
99.0%
in 2025
Oman
99.0%
in 2025
Hungary rank
1st
Oman rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Hungary
- Oman
How they compare
Hungary currently reports 99.0% against 99.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Oman ahead.
Hungary ranks 1st and Oman ranks 1st of 194 countries.
Across the 3 decades both report, Hungary averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Hungary | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 48.0% | 48.0% | Oman |
| 2010s | 84.8% | 98.8% | 14.0% | Oman |
| 2020s | 99.0% | 98.7% | 0.3% | Hungary |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Hungary or Oman?
- Hungary, at 99.0% against 99.0% in Oman as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Hungary and Oman?
- 0.0%, with Hungary ahead.
- How many years of comparable data are there for Hungary and Oman?
- 18 years are reported by both, from 2008 to 2025.
- How do Hungary and Oman rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Hungary ranks 1st and Oman ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.